
Ron Wyden @RonWyden
This is further evidence that Congress must pass drug pricing reforms as soon as possible. I will continue fighting tooth and nail to give Medicare the tools it needs to fight back against high prices and deliver relief to seniors. — PolitiTweet.org
Larry Levitt @larry_levitt
New from CBO: The average net price for brand-name drugs in Medicare more than doubled 2009-2018, versus about 50%… https://t.co/8i762aTyxO